Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
25 studies found for:    Open Studies | "Duodenal Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Duodenal Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Endoscopic Characteristics of Duodenal and Ampullary Lesions
Condition: Duodenal Diseases
Intervention: Other: Tissue Sampling
2 Unknown  Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
Condition: Peptic Ulcer
Intervention: Drug: esomeprazole
3 Recruiting Sublingual Administration of PPI
Condition: Gastric or Duodenal Ulcer
Intervention:
4 Recruiting Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Condition: Peptic Ulcer
Interventions: Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
5 Recruiting Efficacy of Hemostasis by Soft Coagulation Using Endoscopic Hemostatic Forceps for Acute Peptic Ulcer Bleeding
Condition: Active Peptic Ulcer Disease/GI Bleeding
Interventions: Device: epinephrine injection plus soft coagulation using hemostatic forceps;   Device: epinephrine injection plus argon plasma coagulation
6 Unknown  Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding
Conditions: Peptic Ulcer;   Hemorrhage
Intervention: Procedure: endoscopic biopsy
7 Recruiting Early Selective Transarterial Embolization (TAE) to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis
Conditions: Bleeding;   Peptic Ulcer;   Arterial Embolization
Interventions: Procedure: TAE;   Procedure: No TAE
8 Recruiting Frequent Ketamine Use and Gastrointestinal, Liver and Biliary Sequelae
Conditions: Gastritis;   Peptic Ulcer Disease;   Cholangiopathy;   Liver Fibrosis
Intervention:
9 Recruiting A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases
Conditions: Gastric Ulcer (GU);   Duodenal Ulcer (DU);   Anastomotic Ulcer (AU);   Non-erosive Reflux Esophagitis Disease (NERD);   Reflux Esophagitis (RE);   Zollinger-Ellison Syndrome
Interventions: Drug: D961H sachet 10 mg;   Drug: D961H capsule 10mg;   Drug: D961H capsule 20 mg
10 Recruiting The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding and the Selection Criteria for Second-look Endoscopy for Patients With Bleeding Peptic Ulcers
Condition: Peptic Ulcer Bleeding
Intervention: Drug: esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden)
11 Recruiting TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy
Conditions: Peptic Ulcer;   Bleeding
Interventions: Procedure: Trans-catheter arterial embolization;   Procedure: Surgery
12 Unknown  Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis
Condition: Peptic Ulcers
Interventions: Drug: Pantoprazole (Pantoloc);   Drug: Lansoprazole (Takepron OD)
13 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
14 Not yet recruiting DLBS2411 Treatment for Ulcer Healing in Non-Bleeding Peptic Ulcers
Condition: Non-Bleeding Peptic Ulcers
Interventions: Drug: Omeprazole;   Drug: Placebo caplet of DLBS2411;   Drug: DLBS2411;   Drug: Placebo capsule of Omeprazole
15 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
16 Unknown  Surveillance of Bleeding Peptic Ulcer Using Wireless Capsule Endoscopy
Condition: Bleeding Peptic Ulcer
Intervention: Device: Endoscopic placement of Capsule endoscope adjacent to the peptic ulcer
17 Recruiting A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Biliary Tract Neoplasms;   Pancreatitis, Chronic;   Duodenal Neoplasms
Intervention: Procedure: pancreaticojejunostomy
18 Unknown  Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy
Conditions: Pancreatic Neoplasms;   Bile Duct Neoplasms;   Ampullary Neoplasms;   Duodenal Neoplasms;   Pancreatitis
Interventions: Procedure: Billroth-II-type reconstruction;   Procedure: Isolated Roux-en-Y type reconstruction
19 Unknown  Helicobacter Pylori Empiric Treatment in Ulcer Bleeding
Condition: Peptic Ulcer Hemorrhage
Interventions: Other: Empirical  Hp eradication;   Other: Eradication treatment guided by a positive test
20 Recruiting Risk Factors of Rebleeding After Peptic Ulcer Bleeding: a Nationwide Cohort Study
Condition: Peptic Ulcer Bleeding
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results    Last Page
Indicates status has not been verified in more than two years